NSG2 抗体 (AA 31-140) (FITC)
-
- 抗原 See all NSG2 (HMP19) 抗体
- NSG2 (HMP19) (Neuron-Specific Protein Family Member 2 (HMP19))
-
抗原表位
- AA 31-140
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This NSG2 antibody is conjugated to FITC
-
应用范围
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 预测反应
- Human,Mouse,Rat,Cow,Pig,Chicken,Rabbit
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human NSG2/HMP19
- 亚型
- IgG
- Top Product
- Discover our top product HMP19 Primary Antibody
-
anti-Neuron-Specific Protein Family Member 2 (HMP19) (C-Term) antibody
Verified HMP19 适用: 小鼠, 大鼠 ELISA, WB, ICC 宿主: 山羊 Polyclonal unconjugated
-
- 应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- NSG2 (HMP19) (Neuron-Specific Protein Family Member 2 (HMP19))
- 别名
- NSG2 (HMP19 产品)
- 别名
- NSG2 antibody, 8.5 antibody, AA989750 antibody, R75287 antibody, neuronal vesicle trafficking associated 2 antibody, neuron specific gene family member 2 antibody, NSG2 antibody, Nsg2 antibody
- 背景
-
Synonyms: HMP19, Neuron-specic protein family member 2, Nsg2, NSG2_HUMAN, Protein p19.
Background: With 181 million base pairs encoding around 1,000 genes, chromosome 5 is about 6 % of human genomic DNA. It is associated with Cockayne syndrome through the ERCC8 gene and familial adenomatous polyposis through the adenomatous polyposis coli (APC) tumor suppressor gene. Treacher Collins syndrome is also chromosome 5 associated and is caused by insertions or deletions within the TCOF1 gene. Deletion of the p arm of chromosome 5 leads to Cri du chat syndrome. Deletion of 5q or chromosome 5 altogether is common in therapy-related acute myelogenous leukemias and myelodysplastic syndrome.
-
